Company
Brisbane, QLD
Every investor coverage indicates participated in a round Hydrexia raised.
Companies Hydrexia acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Hydrexia. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Venture fund Uniseed led a million-dollar slice of probiotic drinks maker PERKii's four-million-dollar round, its first deal from its new $50 million fund, to fund a national launch.
GBS Ventures reports Novartis has agreed to acquire chronic-pain drug developer Spinifex Pharmaceuticals for US$200 million upfront plus milestones, recalling the company's 2005, 2008 and 2014 venture rounds and its Australian investors.
Also GBS Ventures·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·novartis.com·clinicalleader.com·Brandon Capital portfolio·Startup Daily·Startup Daily·Startup Daily·anthillonline.com·@AuManufacturing·materresearch.org.au·Business News Australia
Air Liquide, through its start-up investment subsidiary ALIAD, has taken an equity stake in HYDREXIA, a Brisbane-based University of Queensland spin-off developing solid magnesium hydride hydrogen storage for industrial markets.